Cell Signal 24:13331343 Soga T, Ohishi T, Matsui T, Saito T, Matsumoto M, Takasaki J, Kamohara M, Hiyama H, Yoshida S, Momose K, Ueda Y, Matsushime H, Kobori M, Furuichi K (2005) Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor
Conception might take longer than expected
Any rapid weight-loss method carries a risk of muscle loss, but GLP-1 medications amplify it because patients eat much less spontaneously
Therefore, it is generally contraindicated in individuals with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Reference [1] FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014 [2] Once-Weekly Semaglutide in Adults with Overweight or Obesity
What the Research Suggests vs